We summarize recent mechanistic and physiological studies related to the role of perilipin 5 (Plin5) in regulating lipid droplet accumulation and protection to fatty acids in tissues with high lipid oxidative metabolism.
INTRODUCTION
The pandemic rise in lipid-associated metabolic disorders has focused interest on the mechanistic actions of cytosolic lipid droplets, the organelles essential for the regulation of lipid homeostasis in both adipose and nonadipose tissues [1,2 & -4 & , 5, 6] . Although the accumulation of excess lipid droplets in nonadipose tissues (ectopic fat) for example, liver, heart, and skeletal muscle, is highly correlated with dyslipidemia, insulin resistance, type 2 diabetes, and cardiovascular disease, studies in mice and humans have demonstrated a more complex relationship, wherein the presence of ectopic fat is more than a simple predictor of metabolic disorder [7, 8, 9 & -11 & ,12]. Thus, lipid droplet function, which balances neutral lipid storage and utilization and is tightly regulated in a cell type-specific manner, is suggested to also have an essential protective role in the sequestration of cytotoxic fatty acids in nonadipose tissues.
Cytosolic lipid droplets are unique storage structures comprised of a core of neutral lipids, triacylglycerols (TAG) and/or cholesteryl ester, surrounded by a phospholipid monolayer. The contrasting chemical natures of hydrophilic lipid metabolic enzymes and their hydrophobic substrates have directed attention to the lipid droplet surface as the regulatory interface between the aqueous cytosol and the hydrophobic lipid core. Specifically, perilipin proteins (Plins) are the definitive abundant proteomic markers of lipid droplet surfaces in both adipose and nonadipose cells and function as primary mediators for neutral lipid storage/hydrolysis [13] [14] [15] .
The mammalian genome encodes five Plin genes, with unique tissue-dependent patterns of transcription and splice variation, although individual cells often express more than a single Plin type [16] . Perilipin 1 (Plin1) is most abundant in white and brown adipose tissues (WAT, BAT). Perilipin 2 (Plin2) and perilipin 3 (Plin3) are more widely distributed, with Plin2 highly expressed in hepatocytes. Perilipin 4 (Plin4) is observed in adipocytes, cardiomyocytes, and myocytes, and perilipin 5 (Plin5) is generally restricted to tissues/cells that utilize lipids for energy through mitochondrial b-oxidation, for example, cardiomyocytes, brown and inducible brown adipocytes (also referred to beige or bright adipocytes), liver, and skeletal myocytes [17] [18] [19] . Here, we review recent progress toward understanding the specialization of Plin5 in the mechanistic interaction of the two critical organelles, lipid droplets and mitochondria, that balance oxidative cellular energy, lipid homeostasis, and cytoprotection.
TRANSCRIPTIONAL REGULATION OF PLIN5 CORRELATES WITH A SPECIALIZED FUNCTION IN CELLS THAT UTILIZE LIPID OXIDATION FOR ENERGY
When exposed to an increase in circulating fatty acids, organs such as heart, skeletal muscle, and liver respond by inducing genes that regulate fatty acid metabolism. One primary pathway involves the transcription factor family of peroxisome proliferator-activated receptors (PPARs) [20] . Upon activation, through direct interaction with fatty acid-derived ligands, PPARs, in combination with their heterodimerization partners, retinoid X receptors (RXRs), bind at specific genomic sequences [PPAR regulatory elements (PPREs)]. Cell-specific expression of PPAR variants, in concert with transcriptional co-factors, such as PGC-1 (PPAR coactivator-1) family members, directs expression of appropriate metabolic enzymes for fatty acid utilization/storage [21] . Accordingly, PPARa and PPARb/d are highly expressed in tissues with elevated rates of fatty acid oxidative metabolism (e.g. heart, skeletal muscle, and liver), whereas PPARg is more preferential in lipogenic tissues (e.g. adipose and liver) [20] .
As an lipid droplet target protein, Plin5 expression is enhanced under physiological or pharmacological conditions that promote systemic fatty acid elevation, for example, fasting (liver, heart), endurance exercise (skeletal muscle), and chronic b3-adrenergic stimulation (liver) [17-19,22,23 & ,24] . Exogenous fatty acids can also stimulate Plin5 expression in cell culture [25] . A functionally conserved PPRE site maps to the first intron of Plin5, and Plin5 expression can be induced in liver, skeletal, and cardiac muscle by PPARa agonists, but also in WAT by pioglitazone, a PPARg agonist [17] [18] [19] 26 && ]. Some agonists, however, are not exclusive, but can cross-activate different PPAR family members.
Although basal Plin5 mRNA levels (liver, heart) are severely suppressed in PPARa À/À mice, Plin5-induced expression is responsive to fasting, suggesting additional regulatory control. Indeed, PPARb/d appears the more potent regulator of Plin5 than PPARa in skeletal muscle [26 && ]. Plins 1, 2, and 4 are similarly induced through fatty acid-ligand activation of PPARs, but their expression is more directly influenced by PPARg action, than by PPARa or PPARb/d [27] [28] [29] [30] .
The preferential activation of Plin5 expression by PPARa and PPARb/d provides a mechanism for selectivity in mammalian tissues that utilize fatty acid for b-oxidation to provide energy or heat. PGC-1a will drive formation of oxidative muscles, fine tune the energy-generating machinery in response to nutrient availability, and promote cellular defenses to metabolic stress [31 & ]. Overexpression of PGC-1a in skeletal muscle will also increase Plin5 transcription [23 & ]. The restricted presence of Plin5 to lipid droplets of oxidative tissues may be required for the physical and functional interactions between lipid droplets and mitochondria and the interplay of fatty acid substrate availability to enable exquisite regulation of b-oxidation for both energy (heart, skeletal muscle) and heat (BAT) [32,33 && ].
KEY POINTS
Plin5 is metabolically and physically linked to lipid droplets and mitochondria in tissues with high b-oxidative activity.
Overexpression of Plin5 in heart promotes steatosis, by inhibiting lipolysis, but in the absence of corresponding cardiac dysfunction.
Cardiac muscle in Plin5 À/À mice has reduced lipid droplet stores, but lipotoxicity that induces cardiac dysfunction.
Plin5 may exert a cytoprotective role against fatty acidinduced lipotoxicity by channeling fatty acid into lipid droplet stores.
UNIQUE PLIN5 REGULATION OF OXIDATIVE LIPID DROPLET STORAGE
Cytosolic lipid droplets are often viewed only as storage depots to provide regulated availability of the lipid moieties required for essential and various cellular functions, including b-oxidation, membrane phospholipid synthesis, cell signaling, and steroid production. Although true, it is now further recognized that lipid droplets also serve a protective function, by sequestering cytotoxic fatty acid and cholesterol, as TAG and cholesteryl ester, respectively [34] [35] [36] . The dynamic nature of lipid droplets balances sequestration and storage, with the regulated cleavage of long-chain TAG to provide sufficient metabolic precursors as polar lipids, while also minimizing cytotoxic effects. The mammalian Plins are not required for lipid droplet biogenesis per se, but as primary regulators of lipolysis, they modulate cellular TAG/cholesteryl ester levels. In general, overexpression of any Plin form can promote lipid droplet storage [13] [14] [15] . Four major proteins, in addition to Plin1, have been identified in the neutral lipid catabolic pathway of adipocytes, hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), comparative gene identification 58 (CGI-58), a positive regulator of ATGL, and G0/G1 Switch (G0S2), a negative regulator of ATGL [37, 38] . In adipocytes, access to lipid droplet surfaces can be regulated by Plin1. Unphosphorylated Plin1 restricts ATGL and HSL from lipid droplets and suppresses lipolysis [39] , whereas PKA-phosphorylated Plin1 permits ATGL/CGI-58 and HSL association with lipid droplet surfaces to activate lipolysis. Thus, under stimulatory conditions that activate adenylyl cyclase and elevate intracellullar cyclic AMP levels, lipolytic rates rise $50-fold [40] . G0S2 inhibits lipolysis through direct interaction with and inhibition of ATGL [38] .
ATGL, HSL, and CGI-58 are also essential regulators of lipid hydrolysis in nonadipose tissue and Plin5 can interact with all three proteins [41-43,44 && ]. Förster resonance energy transfer (FRET) experiments indicate that ATGL and CGI-58 bind toward the C-terminal half of Plin5, whereas the HSL-binding sites are thought to reside in the N-terminal domain that is common to all perilipins [42] . The precise interactive sites on Plin5 are not known, but binding of ATGL and CGI-58 to Plin5 appears to be mutually exclusive [24, 41] . However, in-vivo associations have not been comparatively explored in oxidative cells that are lipolytically dormant or activated. Although G0S2 is expressed in oxidative tissues, a functional role in control of lipolysis is not yet defined.
Plin5 acts to protect lipid droplet stores, likely by suppressing lipolysis. Thus, cardiomyocytes that && ], ATGL-mediated lipolysis is significantly inhibited using Plin5-coated lipid droplet substrates in contrast to lipid droplet controls, isolated from cells that do not express Plin5 [45 && ]. Thus, Plin5 is modeled as a regulated lipolytic barrier that sequesters lipid droplet substrates from ATGL [45 && ]. Cellular lipolytic activation could elicit a structural reorganization of Plin5 at the lipid droplet surface to facilitate ATGL/CGI-58 (and perhaps HSL) access to lipid substrates (Fig. 1a ). In this context, ATGL/CGI-58 interactions are elevated in contracted muscle cells relative to resting cells, without an accompanying alteration in relative Plin5 association with either ATGL or CGI-58 [49] . A potential role for HSL is not defined, but HSL phosphorylation at serine 600 is increased during endurance exercise [50 & ]. Several observations suggest possible mechanistic targets that could modulate ATGL/lipid droplet access. As the binding of ATGL and CGI-58 to Plin5 is mutually exclusive, ATGL may associate with lipid droplets in basal oxidative cells, while being sequestered from its co-activator CGI-58 (Fig. 1b) . A regulatory path that multimerizes Plin5 could facilitate interactions of proximal ATGL and CGI-58 to elicit efficient lipolysis [24] . Plin5 may also reside in nonlipid droplet cellular compartments [51, 52] . Although it is suggested that Plin5 may undergo repartitioning to or from lipid droplets to facilitate lipolytic activation, a differential recruitment of Plin5 to lipid droplets has not been observed in contracted muscle [53] .
Recent proteomic [54] and phospholabeling [43] studies indicate phosphorylation target sites on Plin5. Differential phosphorylation of Plin5 could alter interactions with ATGL and/or CGI-58, thus limiting or activating TAG hydrolysis [43, 55] (Fig. 1c ). Although this has analogy to Plin1 function, functional differences to Plin1 are evident. Unlike Plin1, which does not interact with ATGL regardless of phospho-state, Plin5 readily binds ATGL. In addition, although the Plin5 kinase(s) have yet to be identified, PKA may be less significantly involved. Although mouse (and human) Plin5 does have a potential PKA phosphorylation site, phospho-incorporation into Plin 5 and lipolysis is elevated less than 2-fold upon adenylyl cyclase activation of a cultured Plin5-cell system [43] .
The precise molecular mechanism(s) by which Plin5 controls oxidative lipid droplet storage remains to be further clarified and the postulated models are not mutually exclusive. Important clues will require definitive identification of Plin5 phosphorylation sites and regulatory kinases. FRET approaches may be considered to probe Plin5 and lipid droplet surfaces. DAG enrichment at the surface of lipid droplets will recruit Plin5 [52] , and Plin5 is preferentially localized to TAG-enriched lipid droplets, in contrast to cholesteryl ester organelles [56 & ]. Studies focused to characterize Plin5/lipid droplet surfaces will help evaluate the ability of Plin5 to regulate substrate/lipase sequestration. However, difficulties in purifying the Plins have limited their use in classical biophysical techniques to investigate Plin/lipid droplet surfaces and regulation of lipase activity [57] . An inhibitory role for G0S2 in oxidative tissue is suggested, but must be investigated mechanistically.
SPECIFIC ROLE OF PLIN5 IN OXIDATIVE CELLS, INVOLVING PHYSICAL LIPID DROPLET-MITOCHONDRIAL ASSOCIATIONS
Plin1, Plin2, and Plin5 regulate lipid droplet storage by separate mechanisms, reflecting their unique adaptations to cell/lipid utilization (Fig. 2) . Plin1 facilitates TAG storage in adipocytes for systemic energy homeostasis, whereas Plin2 is expressed more globally to allow TAG storage (ectopic fat) under conditions of starvation or obesity. Plin5 in myocytes and other oxidative cells balances fatty acid availability for mitochondrial oxidation with sequestration to protect against cytotoxicity. Lossof-function mutants for Plin1, 2, or 5 all have decreased lipid droplet stores and increased b-oxidation in their respective tissues, compared with wild type [48 && ,58,59,60 && ], despite compensating expression by other Plin forms; Plin1 À/À adipocytes have increased Plin2 at their lipid droplet surface, but elevated rates of lipolysis. As Plin2 is unable to compensate for Plin1 for lipolytic regulation, Plin1 À/À mice are protected to diet-induced obesity [58, 59] . Plin2 À/À hepatocytes have increased Plin5, but also a marked reduction in lipid droplet content in response to starvation or high-fat diet [61,60 && ]. Although Plin5 may be less protective to lipid droplet accumulation in hepatocytes than is Plin2, overexpression of Plin5 in Plin2 þ/þ hepatocytes can increase TAG storage [62] . Certainly, Plin5 (and the other Plin forms) may respond and function with extreme cell-type specificity, but importantly, Plin1, Plin2, and Plin5 are not simply operationally redundant for lipid droplet storage and regulation.
In oxidative tissues, Plin5 is localized at the surface of lipid droplets and in association with mitochondria [32,33 && ]. Overexpression of Plin5 in fibroblasts directs a close association of lipid droplets and mitochondria [32] . Although Plin2 alone is unable to promote a similar reorganization, a Plin2 chimera with the C-terminal 67 amino acids of Plin5 (including 20 essential amino acids) has the ability to tether mitochondria to lipid droplets in mammalian cultured cells [32] .
The physiological significance to promote the association of lipid droplets and mitochondria in oxidative tissue is yet to be determined. However, mitochondria/lipid droplet associations, observed in heart and skeletal muscle cells where lipids are utilized for energy, are further enhanced by exercise [63] . In accord, exercise in mice and humans increases PGC-1a expression in skeletal muscle, which promotes expression of Plin5 and other genes involved in lipid droplet assembly and mobilization and remodeling of mitochondria [23 & ]. An intimate physical association between lipid droplets and mitochondria in oxidative tissue may not only be essential to coordinate cellular energy homeostasis, but also to protect mitochondria against locally elevated toxic levels of fatty acid and lipid intermediates. Ultimately, lipid droplets can utilize the same substrates as mitochondria (Fig. 2) , so increased lipid droplet storage can be protective to fatty acid cytotoxicity [64 & ]. In addition, elevated rates of fatty acid b-oxidation contribute to increased mitochondrial reactive oxygen species (ROS) [64 & ]. Plin5 may reduce ROS production by transiently channeling excess fatty acid into lipid droplets. Although lipid droplet storage is a hallmark of cellular stress, it may serve more to ameliorate cytotoxicity, rather than to be a causal agent.
The regulated hydrolysis of TAG in Plin5-lipid droplets may not only direct fatty acids to the mitochondria, but may also provide functional signals for PPARa and PPARb/d activation. More specifically, a PPAR ligand has been proposed that is derived from ATGL-mediated lipid droplet hydrolyses [47] and that may regulate expression of genes involved in fatty acid metabolism, mitochondrial biogenesis, and protective antioxidative pathways [ 
PLIN5 IN CARDIAC/SKELETAL MYOCYTE FUNCTION AND SYSTEMIC HOMEOSTASIS
Although there is direct relationship between Plin5 expression levels and lipid droplet accumulation, connections among b-oxidation, ROS, and cardiac function are less well defined. Whole-body loss-offunction Plin5 À/À mice have not only depleted cardiac lipid droplets, increased b-oxidation, but also increased ROS production and cardiac dysfunction, which may be minimized with antioxidative therapy [48 && ]. Cardiac-specific overexpression of Plin5 in mice results in massive steatosis, a mild defect in mitochondria b-oxidation, but also increased ROS, without cardiac dysfunction [44 && ]. Although here, the Nrf2-antioxidant response pathway is activated, which increases expression of the protective glutathione enzymes [44 && ], a mechanistic link of Plin5, increased lipid droplets, and Nrf2 activation is yet to be established; the ROS sources in Limited intracellular fatty acid is utilized for mitochondrial oxidation. Plin2 and liver: Excess fatty acid supply leads to an increase in triacylglycerol (TAG) biogenesis, stored as Plin2-coated lipid droplets (ectopic fat) or secreted as ApoBcoated lipoprotein particles. Some intracellular fatty acids are available for mitochondrial oxidation. Plin5 and cardiac/skeletal muscle: A significant degree of excess fatty acid supply is utilized for mitochondrial oxidation. Additional fatty acids are directed to TAG biogenesis, which is stored as Plin5-coated lipid droplets, tethered to mitochondria. TAG storage in Plin5-lipid droplets may protect mitochondria from fatty acid toxicity and promote mitochondrial function. ]. Systemic and tissuespecific functions remain to be investigated under conditions of obesity, exercise, and cold challenge [48 && ]. Relation to insulin sensitivity can only be partially inferred. Selective skeletal muscle Plin5 overexpression results in increased muscle lipid droplet content, a gene expression profile favoring b-oxidation, but without compromising or improving muscle sensitivity for insulin-mediated glucose uptake during diet-induced obesity [73 && ]. By contrast, overexpression of Plin2 in skeletal muscle also leads to increased lipid droplet stores, but suppressed b-oxidation and partially improved muscle insulin-mediated glucose uptake in response to dietinduced obesity [74 & ]. Plin specificity at lipid droplet surfaces may differentially impact lipid stores in oxidative tissue (Fig. 2) . Plin5 may participate more in an adaptive cell mechanism in response to higher rates of fatty acid b-oxidation by mitochondria.
CONCLUSION
The Plin5 studies underscore the concept for specialized pools of 'oxidative' lipid droplets in highly energetic mammalian cells. In contrast to other Plin forms, Plin5 has the unique ability for lipid droplet storage during energetic demands of fatty acid oxidation and to promote the close proximity of lipid droplets with mitochondria, the oxidative site.
It may be speculated that lipid droplet-mitochondrial associations assure advantageous fuel delivery for energetic efficiency and also provide a localized cytoprotective sink for excess toxic fatty acid. The mechanistic functions of Plin5 are still to be fully elaborated, but Plin5 remains a focus to understand the adaptive cellular mechanisms to high lipid oxidative metabolic states and their failure in earlier stages of metabolic disease.
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